HOOK - HOOKIPA Pharma Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 0.768

Open

$ 0.79

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.75 - $ 0.80

52 Week Range

$ 0.41 - $ 2.05

Volume

623,571

Average Volume

Market Cap

75.99M

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-22-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-15-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-24-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-12-2021	03-31-2021	10-Q
14	03-18-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-Q
17	05-14-2020	03-31-2020	10-Q
18	03-19-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-12-2019	06-30-2019	10-Q
21	05-20-2019	03-31-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beat...
05/09/2024 11:15:43

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10...

Breaking Down HOOKIPA Pharma: 4 Analysts S...
04/26/2024 12:00:23

HC Wainwright & Co. Maintains Buy on HOOKI...
04/26/2024 10:55:31

HC Wainwright & Co. analyst Arthur He maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and lowers the price target from...

HOOKIPA Pharma Announced Its Final Pivotal...
04/25/2024 11:24:43

why-is-penny-stock-hookipa-pharma-trading-higher-on-wednesday

Why Is Penny Stock HOOKIPA Pharma Trading ...
04/24/2024 14:31:37

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about ...

HOOKIPA Pharma shares are trading higher a...
04/24/2024 11:51:18

HOOKIPA Pharma Received FDA Clearance For ...
04/24/2024 11:02:36

roches-lymphoma-drug-with-chemo-extends-survival-in-pretreated-patients

Roche's Lymphoma Drug With Chemo Extends S...
04/15/2024 12:56:25

Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + G...

HOOKIPA Pharma Announced That Members Of I...
04/10/2024 11:10:35

RBC Capital Reiterates Outperform on HOOKI...
03/25/2024 14:25:13

RBC Capital analyst Brian Abrahams reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and maintains $5 price target.

HC Wainwright & Co. Reiterates Buy on HOOK...
03/25/2024 10:25:07

HC Wainwright & Co. analyst Arthur He reiterates HOOKIPA Pharma (NASDAQ:HOOK) with a Buy and maintains $6.5 price target.

HOOKIPA Pharma: Q4 Earnings Insights
03/22/2024 13:20:05

HOOKIPA Pharma Q4 EPS $(0.22) Misses $(0.1...
03/22/2024 11:03:38

HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0....

roche-terminates-cancer-drug-pact-with-repare-therapeutics-its-second-walkout-within-a-month

Roche Terminates Cancer Drug Pact With Rep...
02/13/2024 13:43:35

Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone a...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
02/08/2024 13:05:59

12 Health Care Stocks Moving In Thursday's...
02/01/2024 13:06:10

RBC Capital Maintains Outperform on HOOKIP...
01/30/2024 15:15:38

RBC Capital analyst Brian Abrahams maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and lowers the price target from...

roche-walks-away-from-hookipa-pharma-partnered-kras-focused-cancer-deal

Roche Walks Away From HOOKIPA Pharma-Partn...
01/29/2024 17:55:20

HOOKIPA Pharma's strategic focus on HB-200 program for HPV16+ HNSCC, infectious disease cure collaboration with Gilead, and...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
01/29/2024 13:06:03

HOOKIPA Pharma Updates Business Priorities...
01/29/2024 13:04:55

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered pro...